Key Findings
The Asia-Pacific 3D bioprinting market is expected to register a CAGR of 16.81% during the forecast period, 2023-2032. The industrial aspects of gene therapy have garnered attention in Korea, Japan, and China, leading to the establishment of several start-ups and a lucrative environment in terms of investments. As a result, the surging demand for gene therapies indirectly boosts the demand for 3D-printed products in the region.

Market Insights
China, South Korea, Australia & New Zealand, Thailand, Japan, India, Singapore, and Rest of Asia-Pacific are evaluated for the Asia-Pacific 3D bioprinting market growth assessment. In India, the government promotes research & development initiatives in regenerative medicine (RM). Also, several complex interlinkages among governments, academia, and industry have facilitated the development of innovative capacity. This is evident in initiatives associated with tissue engineering, gene therapy, stem cell & cord blood banking, gene therapy, 3D bioprinting, and biomaterials.
In Singapore, researchers at the Singapore Institute of Manufacturing Technology were able to create realistic colorations on printed samples by regulating melanin production in bioink (November 2019). In August 2020, researchers from the Singapore University of Technology and Design (SUTD) demonstrated a new level of control in the directed differentiation of stem cells by means of a printed micro-scaled physical device. Moreover, the Nanyang Technological University Singapore (NTU Singapore) scientists used sunflower pollen to develop a 3D printing ink material that can be used to fabricate parts useful for drug delivery, toxicity testing, and tissue engineering. Such factors offer growth opportunities for the analyzed market in these countries.

Competitive Insights
Some of the leading companies in the market are ROKIT Healthcare Inc, Organovo Holdings Inc, GeSiM GmbH, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments